These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8373918)

  • 1. Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.
    Power AC; Dorkins CE; Cowen PJ
    Biol Psychiatry; 1993 Jun 1-15; 33(11-12):801-5. PubMed ID: 8373918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men.
    Walsh AE; Oldman AD; Franklin M; Fairburn CG; Cowen PJ
    J Affect Disord; 1995 Feb; 33(2):89-97. PubMed ID: 7759666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.
    Quattrone A; Tedeschi G; Aguglia U; Scopacasa F; Direnzo GF; Annunziato L
    Br J Clin Pharmacol; 1983 Nov; 16(5):471-5. PubMed ID: 6639832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA; Roberts A; Montgomery SA; Cowen PJ
    Br J Psychiatry; 1997 Sep; 171():280-2. PubMed ID: 9337985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
    Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
    J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB; Williamson DJ; Cowen PJ
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats.
    Aulakh CS; Zohar J; Wozniak KM; Hill JL; Haass M; Murphy DL
    Pharmacol Biochem Behav; 1991 May; 39(1):91-5. PubMed ID: 1924518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone reduces the fenfluramine-induced prolactin release in man.
    Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine.
    Reist C; Mazzanti C; Vu R; Tran D; Goldman D
    Am J Med Genet; 2001 May; 105(4):363-8. PubMed ID: 11378851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
    Glue PW; Cowen PJ; Nutt DJ; Kolakowska T; Grahame-Smith DG
    Psychopharmacology (Berl); 1986; 90(3):398-402. PubMed ID: 3097730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration.
    O'Keane V; O'Hanlon M; Webb M; Dinan T
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):289-92. PubMed ID: 1879060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-fenfluramine challenge in posttraumatic stress disorder.
    Davis LL; Clark DM; Kramer GL; Moeller FG; Petty F
    Biol Psychiatry; 1999 Apr; 45(7):928-30. PubMed ID: 10202582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolactin response to d- and l-fenfluramine and to d-amphetamine in human subjects.
    Feeney S; Goodall E; Silverstone T
    Int Clin Psychopharmacol; 1993; 8(1):49-54. PubMed ID: 8473721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.